Dow Down 0.25% Nasdaq Down 0.26%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
123.95 0.89(0.72%) Aug 28, 3:59PM EDT
Prev Close:123.06
Open:122.61
Bid:69.50 x 700
Ask:129.00 x 100
1y Target Est:160.19
Beta:1.12
Next Earnings Date:N/A
Day's Range:122.47 - 126.22
52wk Range:82.51 - 154.89
Volume:524,767
Avg Vol (3m):1,081,750
Market Cap:9.33B
P/E (ttm):71.44
EPS (ttm):1.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PCYCUp 0.72%9.33B
CTIC368.36M
MRK173.08B

Key Statistics

Forward P/E (1 yr):243.04
P/S (ttm):21.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.36
Quarterly EPS Est (Sep-14) :0.40
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2,151.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback